Literature DB >> 26550113

IL-6/STAT3/SOCS3 signaling pathway playing a regulatory role in ulcerative colitis carcinogenesis.

Ying-Ying Chen1, Zhi-Bin Ma1, Hong-Yu Xu1, Li-Jun Shi1, Dong-Yue Li1, Li-Ying Sun1, Xun-Hai Yin1, Guo-Yin Sang1, Dan Xu1, Yin-Hua Tang1, Xi Wang1, Peng Li1, Feng Wu1, Jin Zhou2.   

Abstract

OBJECTIVE: Large-scale clinical studies have shown that ulcerative colities were related with colorectal cancer. In this study, animal model was established by AOM/DSS method to explore the activation of IL-6-STAT3-SOCS3 signaling pathway and the expression of pathway-related proteins in ulcerative colitis carcinogenesis, in order to lay a foundation for exploring the regulation mechanism of IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis carcinogenesis.
METHOD: AOM/DSS modeling method was used to establish animal models of ulcerative colitis carcinogenesis; colonic mucosa specimens were collected at different time points for pathological examination. Immunohistochemical method and western blot were used to detect the expression of IL6, STAT3 and SOCS3 protein in the control group, UC model + empty vector group and UC model + STAT3 knockout group.
RESULTS: In UC model + empty vector group, IL6 and STAT3 expression was increased as lesion degree increased (P < 0.05). The expression of SOCS3 was weakened and the degree of activation decreased (P < 0.05). IL6 expression increased in UC model + STAT3 knockout group (P < 0.05) while the expression of SOCS3 decreased; compared with the UC model + empty vector group, there was a significant difference (P < 0.05).
CONCLUSION: The expression and activation of IL6 and STAT3 expression were enhanced in ulcerative colitis carcinogenesis, and their expression increased with the lesion degree increased, reflecting the disease progression to a certain extent. The expression and activation of SOCS3 expression decreased. STAT3 had a certain effect on the expression of SOCS3, playing a certain regulatory role in ulcerative colitis carcinogenesis.

Entities:  

Keywords:  IL-6; SOCS3; STAT3; Ulcerative colitis; signaling pathways

Year:  2015        PMID: 26550113      PMCID: PMC4612798     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

1.  Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells.

Authors:  Saritha Chakilam; Muktheshwar Gandesiri; Tilman T Rau; Abbas Agaimy; Mahadevan Vijayalakshmi; Jelena Ivanovska; Ralph M Wirtz; Jan Schulze-Luehrmann; Natalya Benderska; Nadine Wittkopf; Ajithavalli Chellappan; Petra Ruemmele; Michael Vieth; Margret Rave-Fränk; Hans Christiansen; Arndt Hartmann; Clemens Neufert; Raja Atreya; Christoph Becker; Pablo Steinberg; Regine Schneider-Stock
Journal:  Am J Pathol       Date:  2013-03       Impact factor: 4.307

Review 2.  Ulcerative colitis-associated colorectal cancer.

Authors:  Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

3.  MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

Authors:  Georgios Koukos; Christos Polytarchou; Jess L Kaplan; Alessio Morley-Fletcher; Beatriz Gras-Miralles; Efi Kokkotou; Mariah Baril-Dore; Charalabos Pothoulakis; Harland S Winter; Dimitrios Iliopoulos
Journal:  Gastroenterology       Date:  2013-07-12       Impact factor: 22.682

4.  High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.

Authors:  An Tao Xu; Yi Li; Di Zhao; Jun Shen; Xi Tao Xu; Yu Qi Qiao; Ming Ming Zhu; Tian Rong Wang; Yun Cui; Luo Yan Ai; Zhi Hua Ran
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

5.  Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.

Authors:  Bhadravathi Marigowda Shivakumar; Harish Rotti; Thanvanthri Gururajan Vasudevan; Aswath Balakrishnan; Sanjiban Chakrabarty; Ganesh Bhat; Lakshmi Rao; Cannanore Ganesh Pai; Kapaettu Satyamoorthy
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

6.  Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.

Authors:  Ru Chen; Sheng Pan; Keith Lai; Lisa A Lai; David A Crispin; Mary P Bronner; Teresa A Brentnall
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 7.  IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Semin Immunol       Date:  2014-02-16       Impact factor: 11.130

8.  STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.

Authors:  Yi Li; Jasper Deuring; Maikel P Peppelenbosch; Ernst J Kuipers; Colin de Haar; C Janneke van der Woude
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

9.  Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis.

Authors:  Yi Li; Yun Tian; Weiming Zhu; Jianfeng Gong; Wei Zhang; Chao Yu; Lili Gu; Ning Li; Jieshou Li
Journal:  Int Immunopharmacol       Date:  2013-04-30       Impact factor: 4.932

10.  STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon.

Authors:  Andrew V Nguyen; Yuan-Yuan Wu; Qiang Liu; Donghai Wang; Stephanie Nguyen; Ricky Loh; Joey Pang; Kenneth Friedman; Amos Orlofsky; Leonard Augenlicht; Jeffrey W Pollard; Elaine Y Lin
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

View more
  10 in total

1.  Polysaccharide extracted from Portulacae Oleracea L. exerts protective effects against dextran sulfate sodium-induced colitis through inhibition of NF-κB.

Authors:  Zheng Wang; Li Wang; Xue Wu; Ya-Lei Pan; Pei Xie; Gang Pei; Yan-Ni Liang; Zhi-Shu Tang; Li Liu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Sphk1 promotes ulcerative colitis via activating JAK2/STAT3 signaling pathway.

Authors:  Jiawen Liu; Bo Jiang
Journal:  Hum Cell       Date:  2019-10-12       Impact factor: 4.174

3.  Association of Aberrant Promoter Methylation Changes in the Suppressor of Cytokine Signaling 3 (SOCS3) Gene with Susceptibility to Crohn's Disease.

Authors:  Golshid Sanati; Davood Jafari; Mehrdad Noruzinia; Naser Ebrahimi Daryani; Mohammad Ahmadvand; Shahram Teimourian; Nima Rezaei
Journal:  Avicenna J Med Biotechnol       Date:  2022 Apr-Jun

4.  Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation.

Authors:  Elisabeth J Shaw; Emily E Smith; Jayde Whittingham-Dowd; Matthew D Hodges; Kathryn J Else; Rachael J Rigby
Journal:  Immun Inflamm Dis       Date:  2017-05-15

5.  The role and gene expression profile of SOCS3 in colorectal carcinoma.

Authors:  Xing Dong; Jing Wang; Bo Tang; Yeng-Xue Hao; Ping-Yang Li; Shi-Yong Li; Pei-Wu Yu
Journal:  Oncotarget       Date:  2017-12-20

6.  Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome.

Authors:  Jiawei Li; Chao Qu; Fangfang Li; Yifang Chen; Jinjuan Zheng; Yao Xiao; Quanxin Jin; Guihua Jin; Xuezhu Huang; Dan Jin
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

7.  Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation.

Authors:  Yingying Chen; Liying Sun; Dongyue Li; Xunhai Yin; Guoyin Shang; Tiantian Diao; Lijun Shi
Journal:  Turk J Gastroenterol       Date:  2022-09       Impact factor: 1.555

8.  MK2: an unrecognized regulator of tumor promoting macrophages in colorectal cancer?

Authors:  Eliseo F Castillo; Anita L Ray; Ellen J Beswick
Journal:  Macrophage (Houst)       Date:  2016-02-01

9.  Regulating the Balance of Th17/Treg via Electroacupuncture and Moxibustion: An Ulcerative Colitis Mice Model Based Study.

Authors:  Jungang Sun; Hejiaozi Zhang; Chengyulin Wang; Mingxiao Yang; Shyang Chang; Yu Geng; Hui Yang; Zhiqi Zhuang; Xiang Wang; Lushuang Xie; Biao Huang; Na Zhao; Wei Zhou; Xinhui Cheng; Bei Cai; Qiaofeng Wu; Shu Guang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-17       Impact factor: 2.629

10.  Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways.

Authors:  Zheng Wang; Xue Wu; Cui-Ling Wang; Li Wang; Chen Sun; Dong-Bo Zhang; Jian-Li Liu; Yan-Ni Liang; Dong-Xin Tang; Zhi-Shu Tang
Journal:  Molecules       Date:  2018-05-02       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.